** Shares of CSPC Pharmaceutical Group 1093.HK jump 12.3% to HK$8.56, their highest since March 2023
** Stock set for the biggest one-day pct rise since November 2022; top pct gainer in the Hang Seng Index .HSI
** CSPC said it is in negotiations with independent third parties on three transactions involving license, collaboration in development, manufacturing and commercialization of certain products with upfront payments amounting to an aggregate $5 bln
** Hong Kong's healthcare index .HSCIH climbs 0.5%, Hang Seng Biotech Index .HSHKBIO gains 0.8%
** YTD, stock up 72.4%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。